← FDA DRUG APPROVALS

FDA ANDA · ANDA207310

SODIUM CHLORIDE

Sponsor: FRESENIUS KABI USA

APPLICATION
ANDA207310
TYPE
ANDA
ORIGINAL APPROVAL
2017-09-19
LATEST ACTION
2022-08-04
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERPrescription
SODIUM CHLORIDE 900MG/100ML · INJECTABLE · INJECTION

Approval history

2022-08-04Manufacturing (CMC) · Supplement 19 · unknownAP
2020-11-19Manufacturing (CMC) · Supplement 12 · unknownAP
2020-07-24Labeling · Supplement 10 · standardAP
2019-10-09Manufacturing (CMC) · Supplement 5 · standardAP
2017-09-19UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →